Sonoma pharmaceuticals and microderm technologies announce that dermodacyn® disinfecting solution is now available in hong kong and thailand

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, disinfectant use and dermatological conditions, and microderm technologies ltd. announce that dermodacyn® disinfectant has received import clearance as a medical device for thailand with the help from microderm's partner vetsynova co.
SNOA Ratings Summary
SNOA Quant Ranking